A Phase 1 interventional study of Lu AG06474 and Placebo to Lu AG06474 in Healthy Participants, sponsored by H. Lundbeck A/S. Completed at 1 site in Netherlands. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-28.
Sponsored by H. Lundbeck A/S · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The main goal of this trial is to learn about the effect of Lu AG06474 on a battery of Evoked Pain Tests when a single dose is given to healthy adult participants. The effects of Lu AG06474 will be compared with 2 approved pain-relieving medications (ibuprofen and pregabalin) and with a placebo (a treatment that looks like the trial treatment but does not have any medicine in it). Each participant will receive 1 dose of each of these treatments during the trial (Lu AG06474, ibuprofen, pregabalin, and placebo), with 1 week between treatments. All treatments will be taken orally (by mouth), either as a liquid or a capsule.
H. Lundbeck A/S is the lead sponsor of 224 studies on the registry; 9 are open to participants now.
Of its 33 completed or terminated interventional studies of FDA-regulated products, 10 (30%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive a single dose of Lu AG06474 (oral solution) and a single dose of placebo (3 placebo capsules).
Drug: Lu AG06474 · Drug: Placebo
Participants will receive a single dose of ibuprofen (3 ibuprofen capsules) and a single dose of placebo to Lu AG06474 (oral solution).
Drug: Placebo to Lu AG06474 · Drug: Ibuprofen
Participants will receive a single dose of pregabalin (1 capsule + 2 placebo capsules) and a single dose of placebo to Lu AG06474 (oral solution).
Drug: Placebo to Lu AG06474 · Drug: Pregabalin · Drug: Placebo
Participants will receive a single dose of placebo to Lu AG06474 (oral solution) and a single dose of placebo (3 placebo capsules).
Drug: Placebo to Lu AG06474 · Drug: Placebo
Oral solution
Oral solution
Capsule
Capsule
Capsule
Change From Baseline in Pain Detection Thresholds (PDTs) for the UVB Heat Pain Test
The PDT is the degrees Celsius where the participant first detects pain.
Time frame: Baseline to 6 hours post-dose
Change From Baseline in Pain Detection Thresholds (PDTs) for the Capsaicin Heat Pain Test
The PDT is the degrees Celsius where the participant first detects pain.
Time frame: Baseline to 6 hours post-dose
Change From Baseline in Area of Secondary Mechanical Allodynia After the Capsaicin Challenge
The area of secondary mechanical allodynia will be reported for the capsaicin challenge, measured in squared millimeters (mm\^2).
Time frame: Baseline to 6 hours post-dose
Change From Baseline in Pain Tolerance Thresholds (PTTs) for the Cold Pressor Test
The PTT is the timepoint (in seconds) where the participant can no longer tolerate the pain.
Time frame: Baseline to 6 hours post-dose
Change From Baseline in Pain Detection Thresholds (PDTs) for the Cold Pressor Test
The PDT is the timepoint (in seconds) where the participant first detects the pain.
Time frame: Baseline to 6 hours post-dose
AUC0-8h: Area Under the Curve Concentration-time Curve from Zero to 8 hours Post-dose
Time frame: 0 (predose) to 8 hours postdose on Day 1 to Day 22
Cmax: Maximum Observed Plasma Concentration
Time frame: 0 (predose) to 8 hours postdose on Day 1 to Day 22
tmax: Nominal Time Corresponding to the Occurrence of Cmax
Time frame: 0 (predose) to 8 hours postdose on Day 1 to Day 22
Difference to Placebo in Blood Levels of Endocannabinoids
Time frame: 0 (predose) to 8 hours postdose on Day 1 to Day 22
Ran from Oct 2023 to primary completion in May 2024, 6 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Ibuprofen · Pregabalin